Key statistics
On Thursday, Enovis Corp (0I1B:LSE) closed at 21.89, 2.77% above its 52-week low of 21.30, set on Jan 28, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | 29.00 |
| Low | 21.89 |
| Bid | -- |
| Offer | -- |
| Previous close | 22.56 |
| Average volume | 243.70 |
|---|---|
| Shares outstanding | 57.19m |
| Free float | 56.25m |
| P/E (TTM) | -- |
| Market cap | 1.30bn USD |
| EPS (TTM) | -24.20 USD |
Data delayed at least 20 minutes, as of Feb 12 2026 18:22 GMT.
More ▼
Announcements
- Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th
- Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Enovis Appoints Oliver Engert as Chief Administrative Officer
- Enovis Announces Third Quarter 2025 Results
- Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences
- Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million
- Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
- Enovis to Participate in Upcoming Investor Conferences
- Enovis Announces Second Quarter 2025 Results
More ▼
